Food and Drug Administration (FDA) in 2005 as a treatment for type 2 diabetes, and later, other versions were introduced for weight loss in medically obese individuals
Greaves DR, Gough PJ, Gordon S
Their large size and rapid enzymatic breakdown in the gastrointestinal tract theoretically reduce bioavailability if transferred into breast milk
Naturally occurring GLP-1 lasts only a few minutes in the body, but the drug form can last up to 14 hours, meaning that effects on appetite also last
However, like all fat reduction treatments, Lemon Bottle leaves other fat cells with the potential for further growth
Weight loss may indirectly improve some metabolic markers, but it does not replace thyroid hormone therapy